Rapid-SF: A Rapid Whole-Blood Screen for Soluble Fibrin Monomer

Summary Thrombosis accounts for a high proportion of disability and death in the West. Although soluble fibrin (SF) assays have been shown to be good predictors of thrombosis, current quantitative assays are too complex or lengthy to provide timely results, while simpler methods are qualitative and lack sensitivity. We here describe a rapid, new, protamine-based whole-blood screening method for SF which is quantitative and suitable for point-of-care use. Citrated whole blood is mixed with reagent under controlled conditions and the time until development of an SF precipitate is measured. Negative samples remain precipitate-free for 300 seconds. Strongly positive samples develop precipitate in as little as 10 seconds. SF times are mathematically converted to arbitrary SF units (SFU). This Rapid-SF test provides a simple and reliable means of detecting the presence of SF, and is well-suited for whole-blood rapid screening in the emergency department, operating room or clinic.

[1]  M. Cupa,et al.  Severe pulmonary embolism associated with air travel. , 2001, The New England journal of medicine.

[2]  H. Arnesen,et al.  Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy , 2000, Thrombosis and Haemostasis.

[3]  C. Dempfle,et al.  The Use of Soluble Fibrin in Evaluating the Acute and Chronic Hypercoagulable State , 1999, Thrombosis and Haemostasis.

[4]  E. Gabazza,et al.  Hemostatic molecular markers before the onset of disseminated intravascular coagulation , 1999, American journal of hematology.

[5]  W. Nieuwenhuizen,et al.  A New Enzyme Immunoassay for Soluble Fibrin in Plasma, with a High Discriminating Power for Thrombotic Disorders , 1999, Thrombosis and Haemostasis.

[6]  B. Lämmle,et al.  Performance of a New Fibrin Monomer Assay to Exclude Deep Vein Thrombosis in Symptomatic Outpatients , 1999, Thrombosis and Haemostasis.

[7]  P. Hannaford,et al.  Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives , 1998, BMJ.

[8]  Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group. , 1998, World Health Organization technical report series.

[9]  World Health Organization Collaborative Study of Cardiov Contarception.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study , 1995, The Lancet.

[10]  J. Douketis,et al.  Evaluation of a Soluble Fibrin Assay in Patients with Suspected Deep Vein Thrombosis , 1995, Thrombosis and Haemostasis.

[11]  K. Huck,et al.  Comparison of Immunological and Functional Assays for Measurement of Soluble Fibrin , 1995, Thrombosis and Haemostasis.

[12]  M. Blombäck,et al.  Soluble fibrin: A predictor for the development and outcome of multiple organ failure , 1994, American journal of hematology.

[13]  M. Blombäck,et al.  Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects , 1993, Acta anaesthesiologica Scandinavica.

[14]  W. Nieuwenhuizen,et al.  A Rapid Monoclonal Antibody-Based Enzyme Immunoassay (EIA) for the Quantitative Determination of Soluble Fibrin in Plasma , 1992, Thrombosis and Haemostasis.

[15]  P. Royston.  Approximating the Shapiro-Wilk W-test for non-normality , 1992 .

[16]  J. Wilson,et al.  Disseminated intravascular coagulation in liver cirrhosis. , 1992, Journal of hepatology.

[17]  C. Hosius,et al.  Determination of soluble fibrin: a comparison of four different methods. , 1992, Thrombosis research.

[18]  S. Halvorsen,et al.  Comparison of methods for detecting soluble fibrin in plasma. An in vitro study. , 1990, Thrombosis research.

[19]  H. Köstering,et al.  Determination of Soluble Fibrin by Turbidimetry of its Protamine Sulphate-Induced Paracoagulation , 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[20]  J. Usero,et al.  The fibrinogen-fibrin complex: stoichiometry and negative cooperativity. , 1985, Thrombosis research.

[21]  P. Wiltzius,et al.  Fibrin aggregation before sol-gel transition. , 1982, Biophysical journal.

[22]  F. Brosstad,et al.  The fibrin-solubilizing effect of fibrinogen as studied by light scattering. , 1979, Thrombosis research.

[23]  E. Brass,et al.  Fibrin Formation: The Role of the Fibrinogen-Fibrin Monomer Complex , 1976, Thrombosis and Haemostasis.

[24]  J. Hawiger,et al.  Electron Microscopy of Fibrin‐like Precipitate Formed during the Paracoagulation Reaction between Soluble Fibrin Monomer Complexes and Protamine Sulphate , 1969, British journal of haematology.